U.S. Pharmaceutical Sales - Q2 2012
The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q2 2012 by units sold
Rank |
Drug |
Units (000) |
|
|
1 ( 1) |
acetaminophen/hydrocodone Generic |
9,529 |
1.59% |
Stats |
2 ( 1) |
budesonide Generic |
9,330 |
-28.55% |
Stats |
3 ( 2) |
Singulair Merck |
7,142 |
3.72% |
Stats |
4 ( 1) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
6,728 |
-15.04% |
Stats |
5 ( 1) |
OneTouch
|
6,647 |
-8.93% |
Stats |
6 |
Nexium AstraZeneca |
6,437 |
-2.05% |
Stats |
7 |
Cymbalta
|
6,235 |
2.20% |
Stats |
8 |
Lantus Sanofi |
5,782 |
-1.72% |
Stats |
9 |
Advair Diskus GlaxoSmithKline |
5,624 |
-3.10% |
Stats |
10 |
Ventolin HFA GlaxoSmithKline |
5,215 |
-8.57% |
Stats |
11 ( 3) |
atorvastatin Generic |
4,248 |
12.83% |
Stats |
12 ( 1) |
Crestor AstraZeneca |
4,036 |
2.80% |
Stats |
13 ( 2) |
fentanyl Generic |
4,013 |
7.36% |
Stats |
14 ( 2) |
Lantus Solostar Sanofi |
3,917 |
4.82% |
Stats |
15 ( 2) |
enoxaparin Generic |
3,828 |
9.75% |
Stats |
16 ( 4) |
AndroGel AbbVie Inc. |
3,516 |
-13.78% |
Stats |
17 ( 1) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,425 |
0.76% |
Stats |
18 ( 7) |
Plavix
|
3,070 |
-41.53% |
Stats |
19 |
Novolog Novo Nordisk |
3,007 |
0.91% |
Stats |
20 ( 1) |
Levemir Novo Nordisk |
2,835 |
3.02% |
Stats |
21 ( 1) |
Nasonex Merck |
2,748 |
-2.48% |
Stats |
22 ( 1) |
NovoLog FlexPen Novo Nordisk |
2,655 |
6.67% |
Stats |
23 ( 2) |
metoprolol Generic |
2,550 |
7.78% |
Stats |
24 |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,495 |
0.28% |
Stats |
25 ( 3) |
Humalog Eli Lilly and Company |
2,465 |
-4.09% |
Stats |
26 ( ) |
Synthroid AbbVie Inc. |
2,339 |
n/a |
Stats |
27 ( 1) |
Januvia Merck |
2,298 |
3.19% |
Stats |
28 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
2,027 |
-3.43% |
Stats |
29 ( 1) |
Namenda Allergan plc |
1,995 |
-2.87% |
Stats |
30 ( 1) |
Lyrica
|
1,982 |
-0.45% |
Stats |
31 |
Zetia Merck |
1,919 |
-1.69% |
Stats |
32 ( 4) |
Symbicort AstraZeneca |
1,915 |
3.51% |
Stats |
33 ( 2) |
Suboxone
|
1,907 |
1.98% |
Stats |
34 ( 4) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
1,904 |
-4.23% |
Stats |
35 ( 1) |
Flovent HFA GlaxoSmithKline |
1,765 |
-6.61% |
Stats |
36 ( 3) |
Actos Takeda Pharmaceutical Company Limited |
1,741 |
-8.94% |
Stats |
37 ( 22) |
escitalopram Generic |
1,727 |
123.42% |
Stats |
38 ( 1) |
Remicade Janssen Pharmaceuticals, Inc. |
1,593 |
2.38% |
Stats |
39 ( 1) |
Lidoderm Endo Pharmaceuticals Inc. |
1,592 |
1.53% |
Stats |
40 |
Lovaza GlaxoSmithKline |
1,549 |
0.78% |
Stats |
41 |
Benicar Daiichi Sankyo |
1,449 |
-1.76% |
Stats |
42 ( 10) |
Lipitor
|
1,398 |
-27.90% |
Stats |
43 |
Dexilant Takeda Pharmaceutical Company Limited |
1,382 |
3.06% |
Stats |
44 ( 1) |
Restasis Allergan plc |
1,327 |
2.79% |
Stats |
45 ( 2) |
OxyContin Purdue Pharma LP |
1,251 |
0.16% |
Stats |
46 |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,209 |
-3.36% |
Stats |
47 ( 3) |
Vytorin Merck |
1,205 |
-8.16% |
Stats |
48 ( 4) |
VESIcare Astellas Pharma US, Inc. |
1,013 |
3.37% |
Stats |
49 ( 4) |
Celebrex
|
999 |
2.25% |
Stats |
50 ( 1) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
983 |
-2.77% |
Stats |
51 ( 3) |
Janumet Merck |
974 |
1.56% |
Stats |
52 ( 2) |
Niaspan AbbVie Inc. |
947 |
-7.61% |
Stats |
53 ( 3) |
Enbrel Amgen Inc. |
878 |
6.68% |
Stats |
54 ( ) |
Evista
|
863 |
n/a |
Stats |
55 |
TriCor AbbVie Inc. |
802 |
-6.85% |
Stats |
56 ( 2) |
Vyvanse Takeda Pharmaceutical Company Limited |
769 |
-2.78% |
Stats |
57 |
Aciphex Eisai Inc. |
761 |
-3.91% |
Stats |
58 ( 2) |
methylphenidate Generic |
731 |
-5.19% |
Stats |
59 ( 2) |
Cialis Eli Lilly and Company |
696 |
5.61% |
Stats |
60 ( 2) |
amphetamine/dextroamphetamine Generic |
658 |
0.61% |
Stats |
61 ( 3) |
Epogen Amgen Inc. |
626 |
12.79% |
Stats |
62 ( 4) |
Humira AbbVie Inc. |
595 |
8.97% |
Stats |
63 ( 2) |
Rituxan Genentech, Inc. |
576 |
5.30% |
Stats |
64 ( 1) |
Truvada Gilead Sciences, Inc. |
574 |
-0.52% |
Stats |
65 ( 2) |
Rebif EMD Serono, Inc. |
572 |
5.93% |
Stats |
66 ( 3) |
Atripla Gilead Sciences, Inc. |
477 |
-2.45% |
Stats |
67 ( 3) |
Avastin Genentech, Inc. |
476 |
3.48% |
Stats |
68 ( 5) |
Viagra
|
448 |
0.45% |
Stats |
69 ( ) |
Victoza Novo Nordisk |
437 |
n/a |
Stats |
70 ( 1) |
Seroquel XR AstraZeneca |
432 |
-3.79% |
Stats |
71 ( ) |
modafinil Generic |
396 |
n/a |
Stats |
72 ( 2) |
Adderall XR Takeda Pharmaceutical Company Limited |
378 |
-10.85% |
Stats |
73 ( 3) |
Neulasta Amgen Inc. |
335 |
1.21% |
Stats |
74 ( 1) |
Lunesta Sunovion Pharmaceuticals Inc. |
334 |
-4.02% |
Stats |
75 ( 3) |
Orencia Bristol-Myers Squibb Company |
330 |
5.10% |
Stats |
76 ( 3) |
Procrit Janssen Pharmaceuticals, Inc. |
316 |
7.12% |
Stats |
77 ( ) |
Mirena Bayer HealthCare Pharmaceuticals Inc. |
306 |
n/a |
Stats |
78 ( ) |
Renvela Sanofi |
294 |
n/a |
Stats |
79 ( ) |
Varivax Merck |
288 |
n/a |
Stats |
80 |
Aranesp Amgen Inc. |
282 |
-3.75% |
Stats |
81 ( 2) |
Eloxatin Sanofi |
281 |
2.55% |
Stats |
82 |
Reyataz Bristol-Myers Squibb Company |
279 |
-1.76% |
Stats |
83 ( 1) |
Erbitux Eli Lilly and Company |
262 |
-1.50% |
Stats |
84 ( 1) |
Isentress Merck |
254 |
4.10% |
Stats |
85 ( 48) |
Seroquel AstraZeneca |
247 |
-85.07% |
Stats |
86 ( 2) |
Copaxone Teva Pharmaceuticals USA, Inc. |
225 |
6.13% |
Stats |
87 ( 2) |
Prezista Janssen Pharmaceuticals, Inc. |
219 |
5.80% |
Stats |
88 ( 1) |
Lucentis Genentech, Inc. |
213 |
-4.91% |
Stats |
89 ( 1) |
Alimta Eli Lilly and Company |
187 |
7.47% |
Stats |
90 ( 1) |
Neupogen Amgen Inc. |
177 |
4.12% |
Stats |
91 ( 2) |
Prevnar 13 Pfizer Inc. |
167 |
7.74% |
Stats |
92 |
Herceptin Genentech, Inc. |
163 |
5.16% |
Stats |
93 ( 1) |
Velcade Takeda Pharmaceutical Company Limited |
159 |
8.90% |
Stats |
94 ( 1) |
Zyvox Pfizer Inc. |
141 |
-2.76% |
Stats |
95 ( 1) |
Avonex Biogen |
132 |
1.54% |
Stats |
96 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
84 |
6.33% |
Stats |
97 ( ) |
Xeloda Genentech, Inc. |
66 |
n/a |
Stats |
98 ( 1) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
59 |
-11.94% |
Stats |
99 ( ) |
Gilenya Novartis Pharmaceuticals Corporation |
49 |
n/a |
Stats |
100 |
Incivek Vertex Pharmaceuticals Incorporated |
22 |
-8.33% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.